The 2024 ELN risk stratification was developed with evidence from an exploratory analysis of pooled data from the phase 3 VIALE-A trial and a phase 1 b study of azacitidine plus venetoclax.

The following is a summary of “Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation,” published in the December ...

The average age of people when they are first diagnosed with AML is about 69. AML is slightly more common among men than women, but the average lifetime risk of getting AML for both sexes is about ½ ...

The updated Anti-Money Laundering (AML) regulations also aim to reduce Turkey’s classification as an AML high-risk country, reinforcing its commitment to transparency. These changes come amidst ...